Ann: Felix device validation testing delayed, page-45

First 45 Last

Share
Profile

Follow
Burntbadly

166 Posts.

19

21/03/21

20:13

Post #: 51930593
Share

Originally posted by kitesurfer1: ↑

I am surprisingly optimistic about the announcement, it really just confirmed what was announced in December that further work needs to be done to the device. It literally states it is an engineering issue and not to do with the core technology/science so I think we'll be fine. It is likely that sales never would have taken off in the early markets due to COVID anyway so if we launch in June-August when everyone is vaccinated and COVID-19 is a thing of the past I don't think we'll lose too much.

I do however have some questions with management now, I just really can't help but shake the feeling there is ZERO commercial hustle with this lot. There is a big difference between being an academic and a business person, they are trashing their professional reputations here by just looking sloppy. Would love to see an ex-Resmed or ex-Cochlear exec with actual passion and desire to take the product out to the general public and really make a difference. Management has a LOT to make up for here if they want to be taken seriously, I'd love a take over now we're at at <50M market cap because it really would be great for the world if we got this out there and changed people's lives.

Expand

I would like to know if this is a University of Newcastle, a Hydrix or Memphasys issue. An engineering problem needs more information I believe. And yes, a better commercialization strategy would be useful!

MEM Price at posting: 7.9¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

What's causing the cost-of-living crisis, and how to navigate it

TLG

Talga Group wins key permit for flagship graphite mine in Sweden